DiabTrend - About the company
DiabTrend is a funded company based in Budapest (Hungary), founded in 2015. It operates as a Provider of app for blood glucose management. The company has 275 active competitors, including 32 funded and 4 that have exited. Its top competitors include companies like BeatO, Glooko and Health2Sync.
Company Details
DiabTrend is a provider of an app for blood glucose management. It allows users to maintain diabetes diary & also provides solutions like blood glucose level measurements, insulin intakes, food intakes, sleep, physical activity & others. Features include google fit and apple health integration, smartwatch integrations, weather tracking, BGL sensor integration via Bluetooth, insulin tracking, food recognizing & many more. It uses artificial intelligence to learn the unique properties of glucose metabolism and provides personalized blood glucose level prediction to the users.
- Website
- diabtrend.com
- Email ID
- *****@diabtrend.com
Sign up to download DiabTrend's company profile
DiabTrend's funding and investors
DiabTrend is a funded company. DiabTrend has 4 institutional investors.
View details of DiabTrend's funding rounds and investors
DiabTrend's founders and board of directors
Founder? Claim ProfileDiabTrend's employee count trend
DiabTrend has 3 employees as of Jun 26. Here is DiabTrend's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
DiabTrend's Competitors and alternates
Top competitors of DiabTrend include BeatO, Glooko and Health2Sync. Here is the list of Top 10 competitors of DiabTrend, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Provider of a smartphone-enabled glucometer and diabetes management app | $50.8M | 68/100 | ||
2nd | Glooko 2010, Palo Alto (United States), Series F | Glucose meter and mobile app for diabetes management | $201M | 67/100 | |
3rd | Health2Sync 2013, Taipei (Taiwan), Series C | Provider of an app for tracking blood glucose level | $30.5M | 56/100 | |
4th | January 2017, San Francisco (United States), Series B | AI-powered precision health platform delivering personalized insights and recommendations | $28.3M | 54/100 | |
5th | Tidepool 2012, San Francisco (United States), Seed | Diabetes data management platform empowering accessible, actionable, and meaningful insights | $1.5M | 51/100 | |
6th | Dr. Diary Co 2017, Seoul (South Korea), Series B | Provider of app for diabetes management | $12.2M | 50/100 | |
7th | LibreLinkUp 2016, Orlando (United States), Unfunded | Provider of diabetes management platform for patients | - | - | 46/100 |
8th | eddii 2018, New York City (United States), Unfunded | Provider of mobile app to monitor diabetes | - | - | 45/100 |
9th | OneTouch Reveal 2011, Malvern (United States), Unfunded | Provider of mobile based application for diabetes management | - | - | 44/100 |
10th | Allez Health 2024, Carlsbad (United States), Series A | Developing biosensor technologies in the field of continuous glucose monitoring | $60M | 44/100 | |
11th | Provider of app for blood glucose management | - | 43/100 |
Looking for more details on DiabTrend's competitors? Click here to see the top ones
DiabTrend's Investments and acquisitions
DiabTrend has made no investments or acquisitions yet.
Reports related to DiabTrend
Here is the latest report on DiabTrend's sector:
Are you a Founder ?
FAQs about DiabTrend
Explore our recently published companies
- Lucid AI Flashcards & Quiz - Poland based, 2026 founded, Unfunded company
- Vedh GPT - 2026 founded, Unfunded company
- Routine Softworks - 2026 founded, Unfunded company
- Pol-Intel - 2026 founded, Unfunded company
- Tuk Tuk - 2026 founded, Unfunded company
- AffinityLogic - 2026 founded, Unfunded company
_1573650474211.webp?format=webp&height=120&width=120)